ALAUNA CHRISTIAN: Open Payments
NPI 1801488275 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,298 in 14 payments from 7 companies in 2025. Trend: 2023 $320 · 2024 $1,258 · 2025 $1,298
Food & beverage: $1,298
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 3 | $306 |
| E.R. Squibb & Sons, L.L.C. | 3 | $282 |
| Otsuka America Pharmaceutical, Inc. | 2 | $226 |
| ABBVIE INC. | 3 | $142 |
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| Novo Nordisk Inc | 1 | $112 |
| Janssen Pharmaceuticals, Inc | 1 | $96 |
Products named: COBENFY, Dyanavel XR, REXULTI, VRAYLAR, UZEDY, Ozempic, INVEGA SUSTENNA, Onyda XR.
Industry payments across MO — which companies pay providers there.
